Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Massachusetts General Hospital
Massachusetts General Hospital
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Sun Yat-sen University
City of Hope Medical Center
Stanford University
Mayo Clinic
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
Washington University School of Medicine
University of Southern California
Zhongnan Hospital
Barbara Ann Karmanos Cancer Institute
Children's National Research Institute
University of Michigan Rogel Cancer Center
Emory University
Dana-Farber Cancer Institute
Hospital Universitario 12 de Octubre
St. Jude Children's Research Hospital
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
University of Wisconsin, Madison
Weill Medical College of Cornell University
Milton S. Hershey Medical Center
Swiss Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Mayo Clinic
Virginia Commonwealth University
Medical University of South Carolina
National University of Ireland, Galway, Ireland
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Milton S. Hershey Medical Center
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
University of Virginia
Singapore General Hospital
Case Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Miami
Virginia Commonwealth University